Nataliya Andreychuk explains what teams must do before letting AI act on their behalf, and how that groundwork becomes a competitive advantage.
In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.
What constitutes a reliable supply chain is changing rapidly.
With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.
At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.
Editor's Picks
